ID   GM10852
AC   CVCL_R607
AS   CVCL_G458
SY   CEPH-1346-NA10852; 1346-8365
DR   CLO; CLO_0023770
DR   BioSample; SAMN00800268
DR   Coriell; GM10852
DR   dbMHC; 48610
DR   GEO; GSM25454
DR   GEO; GSM25455
DR   GEO; GSM316435
DR   GEO; GSM316436
DR   GEO; GSM316437
DR   GEO; GSM420628
DR   GEO; GSM420629
DR   GEO; GSM648966
DR   GEO; GSM905844
DR   GEO; GSM905939
DR   GEO; GSM906034
DR   IGSR; NA10852
DR   IHW; IHW01088
DR   IPD-IMGT/HLA; 25886
DR   Wikidata; Q54844685
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134602.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,11:01; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:01,05:01; DQB1*02:01,05:03:01; DRB1*03:01,14:01; DRB3*01,02 (IPD-IMGT/HLA=25886).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: CNV analysis.
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 22
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=16809669; DOI=10.1101/gr.5320706;
RA   Cheung V.G., Ewens W.J.;
RT   "Heterozygous carriers of Nijmegen breakage syndrome have a distinct
RT   gene expression phenotype.";
RL   Genome Res. 16:973-979(2006).
//
RX   PubMed=20856902; DOI=10.1371/journal.pbio.1000480;
RA   Cheung V.G., Nayak R.R., Wang I.X.-R., Elwyn S., Cousins S.M., Morley M.,
RA   Spielman R.S.;
RT   "Polymorphic cis- and trans-regulation of human gene expression.";
RL   PLoS Biol. 8:e1000480.1-e1000480.14(2010).
//
RX   PubMed=21397061; DOI=10.1016/j.ajhg.2011.02.004;
RA   Campbell C.D., Sampas N., Tsalenko A., Sudmant P.H., Kidd J.M.,
RA   Malig M., Vu T.H., Vives L., Tsang P., Bruhn L., Eichler E.E.;
RT   "Population-genetic properties of differentiated human copy-number
RT   polymorphisms.";
RL   Am. J. Hum. Genet. 88:317-332(2011).
//